Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
-
Information for professionals for Cansartan-Mepha plus 8/12.5
-
Änderungen
-
07.03.2019
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
2 Änderungen an Fachinfo Cansartan-Mepha plus 8/12.5
-
Candesartan Cilexetil* (N=2477) Kontrollgruppe* (N=2460) Relatives Risiko (95% CI) p-Wert
+
Candesartan Cilexetil* (N=2477) Kontrollgruppe* (N=2460) Relatives Risiko (95% CI) p-Wert
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
